tradingkey.logo

Intelligent Bio Solutions Inc

INBS
0.930USD
0.0000.00%
Fechamento 11/04, 16:00ETCotações atrasadas em 15 min
6.81MValor de mercado
PerdaP/L TTM

Intelligent Bio Solutions Inc

0.930
0.0000.00%

Mais detalhes de Intelligent Bio Solutions Inc Empresa

Intelligent Bio Solutions Inc. is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its segment includes Commercially available Intelligent Fingerprinting Products and Development Stage Biosensor Platform Technology. Its product portfolio includes Intelligent Fingerprinting Platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader, and a two-part system that consists of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Biosensor Platform is designed to detect multiple biological analytes by substituting the top enzyme layer of the biosensor to suit each analyte and to develop a range of Point of Care Tests, including the modalities of clinical chemistry, immunology, tumor markers, allergens, and endocrinology.

Informações de Intelligent Bio Solutions Inc

Código da empresaINBS
Nome da EmpresaIntelligent Bio Solutions Inc
Data de listagemDec 23, 2020
CEOMr. Harry Simeonidis
Número de funcionários16
Tipo de títulosOrdinary Share
Fim do ano fiscalDec 23
Endereço135 W 41St St,
CidadeNEW YORK
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal10036
Telefone16467905756
Sitehttps://ibs.inc/
Código da empresaINBS
Data de listagemDec 23, 2020
CEOMr. Harry Simeonidis

Executivos da empresa Intelligent Bio Solutions Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Harry Simeonidis
Mr. Harry Simeonidis
President, Chief Executive Officer
President, Chief Executive Officer
40.41K
--
Mr. Jonathan S. Hurd
Mr. Jonathan S. Hurd
Independent Director
Independent Director
63.00
--
Mr. Valter Pinto
Mr. Valter Pinto
Managing Director
Managing Director
--
--
Dr. Steven Boyages, Ph.D.
Dr. Steven Boyages, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Spiro Sakiris
Mr. Spiro Sakiris
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Nicola Fraser
Ms. Nicola Fraser
Independent Director
Independent Director
--
--
Mr. Jason Isenberg
Mr. Jason Isenberg
Independent Director
Independent Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Harry Simeonidis
Mr. Harry Simeonidis
President, Chief Executive Officer
President, Chief Executive Officer
40.41K
--
Mr. Jonathan S. Hurd
Mr. Jonathan S. Hurd
Independent Director
Independent Director
63.00
--
Mr. Valter Pinto
Mr. Valter Pinto
Managing Director
Managing Director
--
--
Dr. Steven Boyages, Ph.D.
Dr. Steven Boyages, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Spiro Sakiris
Mr. Spiro Sakiris
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Nicola Fraser
Ms. Nicola Fraser
Independent Director
Independent Director
--
--

Detalhamento da receita

Moeda: USDAtualizado em: seg, 6 de out
Moeda: USDAtualizado em: seg, 6 de out
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
Sem dados
Por RegiãoUSD
Nome
Receita
Proporção
United Kingdom
2.87M
93.96%
Rest of world
132.70K
4.35%
Australia
29.17K
0.96%
Americas
22.64K
0.74%
Por Empresa
Por Região
Sem dados

Distribuição de ações

Atualizado em: qui, 2 de out
Atualizado em: qui, 2 de out
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Alyeska Investment Group, L.P.
6.76%
Sakiris (Spiro Kevin)
0.59%
Geode Capital Management, L.L.C.
0.57%
Simeonidis (Harry)
0.45%
The Vanguard Group, Inc.
0.17%
Outro
91.46%
Investidores
Investidores
Proporção
Alyeska Investment Group, L.P.
6.76%
Sakiris (Spiro Kevin)
0.59%
Geode Capital Management, L.L.C.
0.57%
Simeonidis (Harry)
0.45%
The Vanguard Group, Inc.
0.17%
Outro
91.46%
Tipos de investidores
Investidores
Proporção
Hedge Fund
6.88%
Individual Investor
1.04%
Investment Advisor/Hedge Fund
0.57%
Investment Advisor
0.20%
Research Firm
0.14%
Outro
91.17%

Participação acionária institucional

Atualizado em: qua, 1 de out
Atualizado em: qua, 1 de out
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q3
31
717.02K
7.90%
-528.70K
2025Q2
34
836.82K
11.26%
+144.79K
2025Q1
36
981.28K
14.20%
+429.65K
2024Q4
38
214.35K
3.16%
-507.92K
2024Q3
38
390.00K
7.80%
-236.97K
2024Q2
42
449.42K
76.55%
-259.12K
2024Q1
46
732.30K
88.07%
+589.21K
2023Q4
40
172.56K
98.30%
+79.74K
2023Q3
42
49.64K
11.24%
+14.21K
2023Q2
43
60.27K
19.45%
+30.17K
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
Alyeska Investment Group, L.P.
613.89K
6.76%
--
--
Jun 30, 2025
Sakiris (Spiro Kevin)
53.93K
0.59%
--
--
Sep 11, 2025
Geode Capital Management, L.L.C.
51.45K
0.57%
+2.44K
+4.98%
Jun 30, 2025
Simeonidis (Harry)
40.41K
0.45%
--
--
Sep 11, 2025
The Vanguard Group, Inc.
15.48K
0.17%
--
--
Jun 30, 2025
Goldman Sachs & Company, Inc.
12.83K
0.14%
+10.00
+0.08%
Jun 30, 2025
Renaissance Technologies LLC
10.90K
0.12%
+10.90K
--
Jun 30, 2025
NBC Securities, Inc.
2.35K
0.03%
+2.35K
--
Jun 30, 2025
National Bank of Canada
350.00
0%
+350.00
--
Jun 30, 2025
Boyages (Steven Constantine)
313.00
0%
--
--
Sep 11, 2025
Ver Mais

ETFs Relacionados

Nome
Proporção
Sem dados

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Tipo
Proporção
Jan 25, 2024
Merger
12→1
Jan 25, 2024
Merger
12→1
Jan 25, 2024
Merger
12→1
Jan 25, 2024
Merger
12→1
Feb 09, 2023
Merger
20→1
Feb 09, 2023
Merger
20→1
Data
Tipo
Proporção
Jan 25, 2024
Merger
12→1
Jan 25, 2024
Merger
12→1
Jan 25, 2024
Merger
12→1
Jan 25, 2024
Merger
12→1
Feb 09, 2023
Merger
20→1
Feb 09, 2023
Merger
20→1
Feb 09, 2023
Merger
20→1
Feb 09, 2023
Merger
20→1
KeyAI